Use of Complementary and Integrative Medicine Among Patients With Glioblastoma Multiforme Seen at a Tertiary Care Center

• Asıl Yazarlar: Amanda Munoz-Casabella MD (Yazar), Dietlind L. Wahner-Roedler MD (Yazar), Ivana T. Croghan PhD (Yazar), Tanya M. Petterson MS (Yazar), Debbie L. Fuehrer LPCC (Yazar), Brent A. Bauer MD (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: SAGE Publishing, 2022-02-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background Glioblastoma multiforme (GBM) is among the most aggressive and lethal tumors, with a median survival of 12-15 months. Many patients use complementary and integrative medicine (CIM) therapies to supplement their cancer treatment. Objective To determine the prevalence of CIM use and identif...